Use of Iron Therapy in Chronic Kidney Disease
Journal: Archives of Clinical Nephrology (Vol.2, No. 1)Publication Date: 2016-05-28
Authors : Jacques Rottembourg; Guy Rostoker;
Page : 001-003
Keywords : Iron complexes; Chronic Kidney diseases; Oral Iron; IV Iron; Allergic reactions; Iron overload;
Abstract
Anemia is a common complication in patients with chronic kidney disease (CKD), and increases with the progression of renal dysfunction [1]. The main cause of anemia is the inadequate production of erythropoietin (EPO), a glycoprotein mainly produced by the kidney responsible for the growth of erythroid cells in the bone marrow [2]. Iron deficiency is another common cause of anemia in these patients and is a major cause of hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) [3]. Approximately, 50% of patients with CKD, who have anemia and are not receiving ESA or iron supplementation show depleted iron stores in their bone marrow [4]. Although the use of intravenous iron in hemodialysis patients has significantly increased during the last decade [5], the appropriate iron dosing strategy in CKD remains debatable.
Other Latest Articles
Last modified: 2018-10-03 20:05:57